Korean J Pediatr Hematol Oncol.  2000 Apr;7(1):146-152.

Two Cases of Juvenile Granulosa Cell Tumor

Affiliations
  • 1Department of Pediatrics, College of Medicine, Gyeongsang National University, Chinju, Korea.
  • 2Department of Internal Medicine, College of Medicine, Gyeongsang National University, Chinju, Korea.
  • 3Department of Obstetrics and Gynecology, College of Medicine, Gyeongsang National University, Chinju, Korea.
  • 4Department of Gyeongsang Institute of Cancer Research, Gyeongsang National University, Chinju, Korea.

Abstract

Juvenile granulosa cell tumor (JGCT) is one of the rare sex cord stromal tumors of the ovary. The majority of JGCT are found in prepubertal girls and young women. Unlike adult granulosa cell tumor (AGCT), JGCT is characterized by high frequency of mitosis and early relapse after treatment. Patients with JGCT in FIGO stage Ia have an excellent outcome with an event-free survival of about 90% following surgical resection alone, while those in advanced stages have an unfavorable outcome. We report two cases of JGCT in stage Ic, who showed a quite different outcome. One was managed initially with surgical resection alone and died of subsequent relapse. Another was managed with multimodality treatments including surgical resection, adjuvant chemotherapy and radiotherapy, and didn't show any evidence of relapse during 16 months of follow-up period. Further studies to evaluate the beneficial effects of chemotherapy and/or radiotherapy are required in patients with JGCT in stage Ic.

Keyword

Juvenile granulosa cell tumor; FIGO stage Ic; Chemotherapy; Radiotherapy

MeSH Terms

Adult
Chemotherapy, Adjuvant
Disease-Free Survival
Drug Therapy
Female
Follow-Up Studies
Granulosa Cell Tumor*
Granulosa Cells*
Humans
Mitosis
Ovary
Radiotherapy
Recurrence
Sex Cord-Gonadal Stromal Tumors
Full Text Links
  • KJPHO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr